Avraham Pharmaceuticals

About:

Avraham Pharmaceuticals, a pharmaceutical company, develops novel products for the treatment and prevention of neurodegenerative disorders.

Website: http://www.avphar.com

Top Investors: Integra LifeSciences, Pontifax, Technion Research & Development Foundation, Clal Biotechnology Industries

Description:

Avraham Pharmaceuticals (“Avraham”) is a privately held, emerging pharmaceutical company developing novel products for treatment and/or prevention of neurodegenerative disorders. Founded in 2010, Avraham has raised $9 million to conduct a European Phase II proof-of-concept efficacy trial in patients with Alzheimer's disease, supporting the development of its lead product candidate, ladostigil.